Scarica l'app Stockscreener
1.465
8.44%
-0.135
Dopo l'orario di chiusura:
1.47
0.005
+0.34%
Precedente Chiudi:
$1.60
Aprire:
$1.7
Volume 24 ore:
116.07K
Relative Volume:
0.99
Capitalizzazione di mercato:
$57.95M
Reddito:
$63.15M
Utile/perdita netta:
$-40.30M
Rapporto P/E:
-0.8772
EPS:
-1.67
Flusso di cassa netto:
$-44.47M
1 W Prestazione:
-13.82%
1M Prestazione:
-26.75%
6M Prestazione:
-43.65%
1 anno Prestazione:
-52.59%
Intervallo 1D:
$1.41
$1.70
Intervallo di 1 settimana:
$1.40
$2.1399
Portata 52W:
$0.8645
$3.26
Tela Bio Inc Stock (TELA) Company Profile
Nome
Tela Bio Inc
Settore
Industria
Telefono
484-320-2930
Indirizzo
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Confronta TELA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.465 | 73.57M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Iniziato | Lake Street | Buy |
| 2019-12-03 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2019-12-03 | Iniziato | Jefferies | Buy |
| 2019-12-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Tela Bio Inc Borsa (TELA) Ultime notizie
Tela Bio at Canaccord Conference: Strategic Growth in Soft Tissue Repair - Investing.com Canada
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates - MSN
Tela Bio reiterates $85M–$88M 2025 revenue target as international expansion accelerates - MSN
TELA Bio Awards Inducement Equity Grants to New Employees - MSN
Will TELA Bio Inc. stock benefit from AI tech trendsSwing Entry Risk Mitigation with Chart Analysis - Newser
TELA Bio Inc. stock trend forecastDaily Breakout List with Smart Filters - Newser
Tools to assess TELA Bio Inc.’s risk profileAI Stock Movement Forecast with Accuracy - Newser
Can trapped investors hope for a rebound in TELA Bio Inc.Free Strong Buy With Technical Confidence - Newser
Tela Bio shares fall 6.88% after-hours following inducement grants to new employees. - AInvest
TELA Bio 2025 Q2 Earnings Net Loss Narrows Amid Revenue Growth - AInvest
TELA Bio Reports Strong Q2 2025 Financial Results - MSN
Is TELA Bio Inc. forming a bottoming baseRetirement Investment Outlook and Return Summary - Newser
TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
TELA Bio Reports Strong Q2 2025 Growth - TipRanks
TELA Bio Reports Second Quarter 2025 Financial Results - GlobeNewswire
TR | OpenAI4o Maintains TELA Bio(TELA.US) With Hold Rating, Maintains Target Price $2 - 富途牛牛
TELA Bio’s Revenue Climbed But Fell Short Of Expectations - Finimize
Contradictions Unveiled: TELA Bio's Q2 2025 Earnings Call Highlights Shifts in Sales Strategy, Product Growth, and Pricing Positioning - AInvest
Tela Bio (TELA): A Compelling Post-Earnings Case for Long-Term Value Creation in a High-Growth MedTech Sector - AInvest
Tela Bio's 2025 Revenue Guidance and Global Expansion: A Strategic Inflection Point for Scalable Growth - AInvest
Earnings call transcript: Tela Bio Q2 2025 sees stock rise despite EPS miss - Investing.com Canada
Tela Bio earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada
Intraday pattern recognizer results for TELA Bio Inc.Daily Stock Watch Summary with Key Insights - Newser
TELA Bio's Q2 Revenue Miss: A Crossroads of Short-Term Pressures and Long-Term R&D Promise in Biotech - AInvest
TELA Bio misses Q2 revenue estimates - MarketScreener
What machine learning models say about TELA Bio Inc.Predicted Market Direction Based on Momentum - Newser
How to use a screener to detect TELA Bio Inc. breakoutsHigh Probability Trade Outcome Prediction - Newser
Is TELA Bio Inc. Stock Overbought or Oversold RSI Indicator AnalysisAI Generated Momentum Stock Forecast Guide - Newser
Using flow based indicators on TELA Bio Inc.Technical Safety Zone Pattern Recognition - Newser
Published on: 2025-08-09 23:56:57 - Newser
TELA Bio (TELA) Projected to Post Earnings on Monday - Defense World
TELA Bio's Equity Strategy: Balancing Talent Retention and Shareholder Value in the MedTech Sector - AInvest
TELA Bio Inc Q2 2025 Earnings Report Preview: Revenue Expected to Reach $20.68 Million, Earnings at -$0.18 per Share. - AInvest
TELA Bio Grants Inducement Stock Units to New Employees - AInvest
TELA Bio TELA 2025Q2 Earnings Preview Upside Potential Driven by Product Expansion - AInvest
TELA Bio Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Strengthens Team with 10,200 Share Incentive Package for 14 Strategic New Hires - Stock Titan
TELA Bio Inc (TELA) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Using fundamentals and technicals on TELA Bio Inc.Daily Market Movers Screener with Filters - Newser
Tela Bio Inc Azioni (TELA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tela Bio Inc Azioni (TELA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Talmo Paul | Chief Technology Officer |
Oct 24 '24 |
Buy |
2.25 |
22,222 |
50,000 |
91,082 |
| KOBLISH ANTONY | Chief Executive Officer |
Oct 24 '24 |
Buy |
2.25 |
88,888 |
199,998 |
458,897 |
| Firestone Gregory A. | Chief Commercial Officer |
Oct 24 '24 |
Buy |
2.25 |
6,666 |
14,998 |
57,279 |
0.31%
1.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):